Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Loeffler

Showing results (161-170 of 238) with videos related to

Pageof 24
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 28, 2001
Resveratrol, a tumor-suppressive compound from grapes, induces apoptosis via a novel mitochondrial pathway controlled by Bcl-2I Tinhofer, D Bernhard, M Senfter, et al.
Leukemia|July 10, 2014
Excellent outcome of young adults with aggressive non-Hodgkin lymphomas treated with CHOP-like regimensK Hohloch, S Zeynalova, G Held, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2009
Favorable impact of the interleukin-4 receptor allelic variant I75 on the survival of diffuse large B-cell lymphoma patients demonstrated in a large prospective clinical trialN Schoof, F von Bonin, S Zeynalova, et al.
Annals of the Royal College of Surgeons of England|June 30, 2021
Safety of emergency, elective and day case operating during the winter period at East Suffolk and North Essex NHS Foundation Trust: lessons from the outcomes of 4,254 surgical patients from the first COVID-19 waveS Parikh, L Cooper, W Matthews, et al.
Cell and Tissue Kinetics|March 1, 1990
Age-related changes in the cell kinetics of rat foot epidermisG M Morris, G J van den Aardweg, R Hamlet, et al.
Cancer Research|March 15, 1990
Increased local antitumor effects of interleukin 2 liposomes in mice with MCA-106 sarcoma pulmonary metastasesP M Anderson, E Katsanis, A S Leonard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2003
Practicability and acute haematological toxicity of 2- and 3-weekly CHOP and CHOEP chemotherapy for aggressive non-Hodgkin's lymphoma: results from the NHL-B trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)A Wunderlich, M Kloess, M Reiser, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 7, 2010
High-dose therapy followed by autologous stem-cell transplantation with and without rituximab for primary treatment of high-risk diffuse large B-cell lymphomaB Glass, M Ziepert, M Reiser, et al.
Leukemia|August 30, 2008
Structural aberrations affecting the MYC locus indicate a poor prognosis independent of clinical risk factors in diffuse large B-cell lymphomas treated within randomized trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)W Klapper, H Stoecklein, S Zeynalova, et al.
Blut|June 1, 1988
Prognostic risk factors in advanced Hodgkin's lymphoma. Report of the German Hodgkin Study GroupM Loeffler, M Pfreundschuh, D Hasenclever, et al.
Pageof 24

Showing results (161-170 of 238) with videos related to

Sort By:
Pageof 24
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 28, 2001
Resveratrol, a tumor-suppressive compound from grapes, induces apoptosis via a novel mitochondrial pathway controlled by Bcl-2I Tinhofer, D Bernhard, M Senfter, et al.
Leukemia|July 10, 2014
Excellent outcome of young adults with aggressive non-Hodgkin lymphomas treated with CHOP-like regimensK Hohloch, S Zeynalova, G Held, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2009
Favorable impact of the interleukin-4 receptor allelic variant I75 on the survival of diffuse large B-cell lymphoma patients demonstrated in a large prospective clinical trialN Schoof, F von Bonin, S Zeynalova, et al.
Annals of the Royal College of Surgeons of England|June 30, 2021
Safety of emergency, elective and day case operating during the winter period at East Suffolk and North Essex NHS Foundation Trust: lessons from the outcomes of 4,254 surgical patients from the first COVID-19 waveS Parikh, L Cooper, W Matthews, et al.
Cell and Tissue Kinetics|March 1, 1990
Age-related changes in the cell kinetics of rat foot epidermisG M Morris, G J van den Aardweg, R Hamlet, et al.
Cancer Research|March 15, 1990
Increased local antitumor effects of interleukin 2 liposomes in mice with MCA-106 sarcoma pulmonary metastasesP M Anderson, E Katsanis, A S Leonard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2003
Practicability and acute haematological toxicity of 2- and 3-weekly CHOP and CHOEP chemotherapy for aggressive non-Hodgkin's lymphoma: results from the NHL-B trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)A Wunderlich, M Kloess, M Reiser, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 7, 2010
High-dose therapy followed by autologous stem-cell transplantation with and without rituximab for primary treatment of high-risk diffuse large B-cell lymphomaB Glass, M Ziepert, M Reiser, et al.
Leukemia|August 30, 2008
Structural aberrations affecting the MYC locus indicate a poor prognosis independent of clinical risk factors in diffuse large B-cell lymphomas treated within randomized trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)W Klapper, H Stoecklein, S Zeynalova, et al.
Blut|June 1, 1988
Prognostic risk factors in advanced Hodgkin's lymphoma. Report of the German Hodgkin Study GroupM Loeffler, M Pfreundschuh, D Hasenclever, et al.
Pageof 24